Whole-brain spatial transcriptomics at cellular resolution [WEBINAR]

For more information, visit: https://www.miltenyibiotec.com/products/ultramicroscope-blaze.html In this video, Dr. Shigeaki Kanatani from the Karolinska Institute in Stockholm, Sweden, provides an overview of TRISCO, a tissueclearing method enabling whole-brain 3D spatial RNA imaging and uniform staining for high-resolution transcriptomic visualization. Dr. Kanatani will give insights into workflow principles behind TRISCO, including RNA preservation, enhanced tissue transparency, and robust staining performance across organs and species. The video highlights how 3D spatial transcriptomic data can be leveraged to study cellular identity and structural organization. Miltenyi Biotec is a global leader in innovating technologies and services for patient-specific cell and gene therapies, turning scientific discoveries into practical treatments for personalized medicine. Having pioneered a groundbreaking method of cell separation, Miltenyi Biotec continues to set industry standards today. With over 35 years of expertise, it supports customers in biomedical discoveries, translating them into clinical applications to enable access to new therapies for patients. Miltenyi Biotec focuses on providing integrated, advanced solutions to address complex challenges in the treatment of cancers, autoimmune diseases, and inherited disorders. Through its Miltenyi Bioindustry division, it provides expert guidance to therapy developers, helping them efficiently and cost-effectively navigate the path from process development to commercialization. Miltenyi Biotec is headquartered in Bergisch Gladbach and has a global team of 4,900 employees across 24 countries.